Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Genet Mol Res ; 14(4): 18026-33, 2015 Dec 22.
Article in English | MEDLINE | ID: mdl-26782450

ABSTRACT

The exotoxin SLT-IIeB from the Escherichia coli Ee strain was expressed in E. coli, and the recombinant protein was purified, mixed with the Ee strain, then emulsified with oil-emulsion adjuvants to obtain a mixed subunit bacterin. Groups of Kunming mice were immunized at weeks 0 and 2, and challenged intraperitoneally with the Ee strain at week 4. Antibodies were detected by ELISA and an agglutination test. After the second immunization, the antibody level increased and the rate of immune protection against the Ee strain was 70 and 91.7% in the subunit bacterin and bacterin groups, respectively. Therefore, the mixed subunit bacterin provided good protection against the homologous Ee strain, which provides a basis for further research, into high-efficacy vaccines against porcine edema disease.


Subject(s)
Bacterial Vaccines/administration & dosage , Edema Disease of Swine/genetics , Escherichia coli Infections/genetics , Shiga Toxin 2/genetics , Animals , Bacterial Vaccines/genetics , Edema Disease of Swine/drug therapy , Edema Disease of Swine/pathology , Enzyme-Linked Immunosorbent Assay , Escherichia coli/genetics , Escherichia coli Infections/drug therapy , Escherichia coli Infections/pathology , Immunization , Mice , Protein Subunits/genetics , Shiga Toxin 2/administration & dosage , Swine/microbiology
2.
Vet Microbiol ; 128(1-2): 160-6, 2008 Apr 01.
Article in English | MEDLINE | ID: mdl-17977672

ABSTRACT

Shiga-toxigenic E. coli (STEC) strains that produce Shiga toxin Stx2e cause oedema disease in weaned piglets. The purpose of the present study was to investigate the impact of Stx2e released in mesenteric lymph nodes on disease pathogenesis. Colistin and ampicillin were intramuscularly administered to piglets of the experimental group simultaneously challenged with STEC strain, type O139:F18ab, Stx2e+. Piglets of the control group were challenged with STEC only. The strain was naturally resistant to ampicillin and susceptible to colistin. After the challenge, colonisation of the intestines was observed in both antibiotic-treated piglets and control piglets without antibiotic treatment. Histochemistry and scanning electron microscopy revealed sporadic colonisation of the small intestine in the piglets. STEC was detected in the mesenteric lymph nodes of untreated piglets. The clinical manifestations of oedema disease were observed in both groups. In the antibiotic-treated group (11 piglets), oedema disease developed in 10 piglets, eight of which died or were euthanized ante finem. In the untreated group (11 piglets), oedema disease developed in five piglets, four of which died or were euthanized ante finem. We therefore propose that the STEC lysed by colistin suddenly released the toxin from bacterial cells immediately after their passage through the intestinal wall. That could explain a more severe course of oedema disease in the treated piglets. Even though high amounts of STEC were present in the lymph nodes of untreated piglets, the toxin was not released abruptly because the bacterial cells were not damaged.


Subject(s)
Anti-Bacterial Agents/pharmacology , Colistin/pharmacology , Edema Disease of Swine/drug therapy , Escherichia coli Infections/veterinary , Shiga-Toxigenic Escherichia coli/pathogenicity , Ampicillin/administration & dosage , Ampicillin/pharmacology , Ampicillin Resistance , Animals , Anti-Bacterial Agents/administration & dosage , Case-Control Studies , Colistin/administration & dosage , Edema Disease of Swine/microbiology , Edema Disease of Swine/mortality , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Escherichia coli Infections/mortality , Feces/microbiology , Injections, Intramuscular/veterinary , Intestines/microbiology , Lymph Nodes/microbiology , Shiga-Toxigenic Escherichia coli/drug effects , Shiga-Toxigenic Escherichia coli/growth & development , Swine , Time Factors , Weaning
3.
J Vet Med Sci ; 66(8): 899-903, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15353838

ABSTRACT

Edema disease (ED) of pigs is an enterotoxaemic disease caused by enterotoxaemic Escherichia coli (ETEEC) infection. Antimicrobial therapy for pigs with ED is controversial because it may induce death of sickish piglets. In this study, we investigated the effects in vitro of 7 antimicrobial agents, ampicillin, gentamicin, colistin, bicozamycin, fosfomycin, sulfamethoxazole-trimethoprim and enrofloxacin, on the release and production of shiga toxin (Stx) 2e by ETEEC strains. We found that more Stx 2e accumulated in the bacterial cells than was released into supernatant. Associated with inhibition of cell wall synthesis, the exposure to ampicillin or fosfomycin increased the release of Stx 2e. The production levels of Stx 2e in all antimicrobial-treated cultures were equal to the level in the control or less than in the control. These results suggest that cell wall synthesis inhibitors, such as ampicillin and fosfomycin, may change for the worse in the signs in ETEEC infectious pigs. On the other hand, gentamicin, colistin, bicozamycin and enrofloxacin may be useful for the treatment of pigs with ED.


Subject(s)
Anti-Bacterial Agents/pharmacology , Edema Disease of Swine/microbiology , Escherichia coli Infections/veterinary , Escherichia coli/drug effects , Shiga Toxin 2/metabolism , Ampicillin/pharmacology , Animals , Anti-Bacterial Agents/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Cell Wall/metabolism , Colistin/pharmacology , Edema Disease of Swine/drug therapy , Enrofloxacin , Escherichia coli/metabolism , Fluoroquinolones/pharmacology , Fosfomycin/pharmacology , Gentamicins/pharmacology , Quinolones/pharmacology , Sus scrofa , Time Factors , Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology
4.
Microbiol Immunol ; 47(1): 57-61, 2003.
Article in English | MEDLINE | ID: mdl-12636254

ABSTRACT

Fifty-seven Shiga toxin-producing Escherichia coli (STEC) strains isolated from pigs with edema disease (ED) from 1997 to 2001 in Japan were examined for antimicrobial susceptibilities. The susceptibilities were compared with those of E. coli ATCC 23546 isolated from pig with ED in the 1950's. Consequently, the isolated STECs showed high susceptibility to peptides and bicozamycin in a way similar to the reference strain. On the other hand, the STECs showed low susceptibility to beta-lactams, tetracyclines, novobiocin, fosfomycin, trimethoprim, and old quinolones. It became clear that the susceptibilities of the isolated STECs had diminished in regard to antimicrobials.


Subject(s)
Edema Disease of Swine/microbiology , Escherichia coli Infections/veterinary , Escherichia coli/drug effects , 4-Quinolones , Animals , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Edema Disease of Swine/drug therapy , Escherichia coli/isolation & purification , Escherichia coli/metabolism , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Fosfomycin/pharmacology , Japan , Lactams , Microbial Sensitivity Tests/veterinary , Novobiocin/pharmacology , Peptides , Swine , Tetracyclines/pharmacology , Trimethoprim/pharmacology
5.
J Vet Med Sci ; 64(1): 71-3, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11853151

ABSTRACT

The in vitro susceptibilities of 285 isolates of Escherichia coli from preweaned and postweaned pigs with diarrhea and edema disease were tested with the 15 commonly used antimicrobial drugs by an agar dilution minimal inhibitory concentration procedure according to National Committee for Clinical Laboratory Standards (NCCLS) guidelines. All E. coli isolates tested in this study belonged to enterotoxigenic E. coli, attaching and effacing E. coli, or Shiga toxin-producing E. coli. Field isolates had low MIC90 for ceftiofur (1 microg/ml). No correlation in antimicrobial resistance was found in three types of E. coli.


Subject(s)
Anti-Bacterial Agents/pharmacology , Edema Disease of Swine/microbiology , Escherichia coli Infections/veterinary , Escherichia coli/drug effects , Animals , Anti-Bacterial Agents/metabolism , Drug Resistance, Bacterial , Edema Disease of Swine/drug therapy , Escherichia coli/pathogenicity , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Korea , Microbial Sensitivity Tests/veterinary , Swine
6.
J S Afr Vet Assoc ; 70(2): 100-1, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10855832

ABSTRACT

From a group of 11 recently weaned pigs, 4 were reported to be sick. Clinical examination of the sick pigs revealed marked dyspnoea, bluish-red discolouration of the skin, incoordination and difficulty in walking. Bacteriological examination of the gut contents of 2 pigs that had died earlier yielded pure cultures of haemolytic Escherichia coli. Post mortem examination of the remaining 2 pigs that died subsequently revealed progressive pulmonary collapse. One of these also showed subcutaneous oedema of the head and marked oedema of the mesentery of the spiral colon and oedema of the brain. Microscopically there was pulmonary alveolar collapse and degenerative changes in the liver. On the basis of the clinical signs, isolation of haemolytic E. coli and the post mortem findings, a diagnosis of oedema disease was made.


Subject(s)
Edema Disease of Swine/etiology , Escherichia coli Infections/etiology , Escherichia coli/isolation & purification , Administration, Oral , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Brain/pathology , Colon , Dihydrostreptomycin Sulfate/administration & dosage , Dihydrostreptomycin Sulfate/therapeutic use , Drug Therapy, Combination , Dyspnea/veterinary , Edema Disease of Swine/drug therapy , Edema Disease of Swine/epidemiology , Escherichia coli Infections/drug therapy , Escherichia coli Infections/epidemiology , Furazolidone/administration & dosage , Furazolidone/therapeutic use , Injections, Intramuscular/veterinary , Kenya/epidemiology , Liver/pathology , Lung/pathology , Mesentery/pathology , Penicillin G Procaine/administration & dosage , Penicillin G Procaine/therapeutic use , Penicillins/administration & dosage , Penicillins/therapeutic use , Swine
7.
Berl Munch Tierarztl Wochenschr ; 107(3): 82-5, 1994 Mar.
Article in German | MEDLINE | ID: mdl-7993343

ABSTRACT

The paper gives an up to date review of our knowledge concerning etiology, clinics and pathogenesis of the edema disease. A therapy protocol is given, an extensive list of original literature for further study is presented.


Subject(s)
Edema Disease of Swine/drug therapy , Escherichia coli Infections/veterinary , Animals , Escherichia coli Infections/drug therapy , Swine , Weaning
8.
Berl Munch Tierarztl Wochenschr ; 106(12): 423-5, 1993 Dec.
Article in German | MEDLINE | ID: mdl-7907469

ABSTRACT

During a natural outbreak of edema disease in different farms 160 weaned piglets showing the clinical symptoms of palpebral edema, mental discomfort and apathy were selected and divided into three groups. The groups were treated as follows: Group 1 (51 piglets) received twice daily one i. m. dose of Gentamycin (11 mg/kg body weight), Prednisolone (1 mg/kg body weight), Melperone (4 mg/kg body weight) for 3 days. Group 2 (55 piglets) received twice daily one i. m. dose of Amphetaminum Phosphoricum 1 mg/kg body weight for 3 days. Group 3 (54 piglets) untreated control. The result showed that group 2 treated with stimulant of the central nervous system gave the best results concerning survival. It ist the authors opinion that concerning clinical symptoms and therapy further classification is necessary.


Subject(s)
Amphetamine/therapeutic use , Central Nervous System Stimulants/therapeutic use , Edema Disease of Swine/drug therapy , Animals , Antipsychotic Agents/therapeutic use , Butyrophenones/therapeutic use , Drug Therapy, Combination , Gentamicins/therapeutic use , Prednisolone/therapeutic use , Swine
9.
Tijdschr Diergeneeskd ; 109(22): 922-7, 1984 Nov 15.
Article in Dutch | MEDLINE | ID: mdl-6515618

ABSTRACT

Long-term treatment (eighteen months) with a medicated feed containing 400 ppm of furazolidone gave rise to side-effects on a pig farm on which the animals were affected with persistent oedema disease. These side-effects disappeared on discontinuation of the medication. In view of this suspected case of chronic furazolidone intoxication the court formulated several questions for a panel of experts. The questions and the replies given are stated.


Subject(s)
Edema Disease of Swine/drug therapy , Furazolidone/poisoning , Swine Diseases/chemically induced , Animal Feed/poisoning , Animals , Food Additives/poisoning , Furazolidone/administration & dosage , Swine
10.
Vet Med Nauki ; 15(1): 78-83, 1978.
Article in Bulgarian | MEDLINE | ID: mdl-80055

ABSTRACT

Employing a microbiologic method (in vitro) the activity was investigated of Gentamicin DSO Pharmachim, dissolved in water, in normal swine gamma-globulin, and in normal swine polyglobulin with regard to swine strains of Escherichia coli, Salmonella choleraesis Bordetella bronchiseptica, and Pseudomonas aeruginosa as well as Mycoplasms. A strong sensitivity was found to exsist in all tested strains (except for the Mycoplasms) to gentamycin both in a water and in a protein solution. The in vivo testing of the therapeutic effect of the two types of solutions in an experimental infection in albino mice revealed that the differences found in the activity of the various gentamicin solutions were statistically insignificant. The step agglutination test was used to follow up the effect of gentamycin on the OK agglutinating antibodies of a gamma-globulin preparation against oedema disease in pigs. Results showed a slight increase in the agglutinating activity of the gamma-globulin antibodies under the effect of the antibiotic.


Subject(s)
Bacteria/drug effects , Gentamicins/pharmacology , Swine/microbiology , Animals , Drug Evaluation, Preclinical/veterinary , Edema Disease of Swine/drug therapy , Escherichia coli Infections/drug therapy , Gentamicins/therapeutic use , In Vitro Techniques , Mice , Microbial Sensitivity Tests , Solutions , gamma-Globulins
SELECTION OF CITATIONS
SEARCH DETAIL
...